Brief: Parenteral Drugs India to consider sale of Kasrawad, Baddi undertakings
Feb 7 (Reuters) - Parenteral Drugs India Ltd PADG.NS
* Says to consider sale of Kasrawad, Baddi undertakings of
co on slump sale basis to unit
Source text: http://bit.ly/2klWqS9
Further company coverage: PADG.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Parenteral Drugs (India)
See all newsBrief: Parenteral Drugs (India) Ops Remain Closed Due To Labour Unrest
Vinod Kumar Gupta Reappointed MD
Brief: Parenteral Drugs India Gets Shareholders' Nod For Sale Of Shares In Infutec Healthcare
Brief: Parenteral Drugs India Seeks Shareholders' Nod To Transfer Kasrawad, WFI Undertaking
Brief: Parenteral Drugs India To Consider Sale Of Kasrawad Undertaking